Your browser doesn't support javascript.
loading
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae.
Dean, Charles R; Barkan, David T; Bermingham, Alun; Blais, Johanne; Casey, Fergal; Casarez, Anthony; Colvin, Richard; Fuller, John; Jones, Adriana K; Li, Cindy; Lopez, Sara; Metzger, Louis E; Mostafavi, Mina; Prathapam, Ramadevi; Rasper, Dita; Reck, Folkert; Ruzin, Alexey; Shaul, Jacob; Shen, Xiaoyu; Simmons, Robert L; Skewes-Cox, Peter; Takeoka, Kenneth T; Tamrakar, Pramila; Uehara, Tsuyoshi; Wei, Jun-Rong.
Affiliation
  • Dean CR; Novartis Institutes for BioMedical Research, Emeryville, California, USA charlesr.dean@novartis.com.
  • Barkan DT; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Bermingham A; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Blais J; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Casey F; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Casarez A; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Colvin R; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Fuller J; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Jones AK; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Li C; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Lopez S; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Metzger LE; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Mostafavi M; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Prathapam R; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Rasper D; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Reck F; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Ruzin A; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Shaul J; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Shen X; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Simmons RL; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Skewes-Cox P; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Takeoka KT; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Tamrakar P; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Uehara T; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Wei JR; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
Antimicrob Agents Chemother ; 62(10)2018 10.
Article in En | MEDLINE | ID: mdl-30061293
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monobactams / Escherichia coli / Klebsiella pneumoniae / Anti-Bacterial Agents Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monobactams / Escherichia coli / Klebsiella pneumoniae / Anti-Bacterial Agents Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States